Sam Kerr feels she can be even better given the right surroundings. The Australian forward is already considered one of the ...
Liquid I.V.™ is building on its position as a powdered hydration leader in the UK with launches in Spain, Germany, France, Sweden and Iceland. The expansion supports Liquid I.V.™'s continued growth to ...
PAS-004 has been well-tolerated, with all treatment-related adverse events (TRAEs) being Grade 1 or 2, no observed cardiac or retinal treatment-related events, and low rates of rash and ...
Genmab A/S(Nasdaq: GMAB) today announced topline results from the Phase 3 EPCORE DLBCL-4 trial evaluating the combination of fixed duration epcoritamab, a T-cell engaging bispecific antibody ...
Company AnnouncementTopline results from Phase 3 EPCORE® DLBCL-4 evaluating epcoritamab in combination with lenalidomide demonstrated ...